SCHEMBL22799151

SCHEMBL22799151

COc1cc(C)cc(OC(=O)c2c(C)cc(OC)cc2O)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.78
POLB P06746 3/20 0.78
CYP3A4 P08684 7/20 0.69
HPGD P15428 4/20 0.69
MAPK1 P28482 3/20 0.61
MEN1 O00255 2/20 0.61
ALDH1A1 P00352 2/20 0.61
ALOX15 P16050 2/20 0.61
HSD17B10 Q99714 1/20 0.61
GLO1 Q04760 1/20 0.52
GAA P10253 2/20 0.51
ACHE P22303 1/20 0.50
PTPN1 P18031 3/20 0.48
PTGES O14684 1/20 0.47
KDM4E B2RXH2 2/20 0.46
MAPT P10636 2/20 0.46
G6PD P11413 1/20 0.46
RECQL P46063 1/20 0.46
MCL1 Q07820 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28891353 0.94 POLB (0.74) KMT2APOLBCYP3A4HPGDMAPK1
SCHEMBL22799229 0.94 KMT2A (0.69) KMT2APOLBCYP3A4HPGDMAPK1
SCHEMBL29814285 0.94 KMT2A (0.69) KMT2APOLBCYP3A4HPGDMAPK1
SCHEMBL29980735 0.89 CYP3A4 (0.87) KMT2APOLBCYP3A4HPGDMAPK1
Evernic Acid SCHEMBL2552354 0.88 POLB (1.00) KMT2APOLBCYP3A4HPGDMAPK1
Lecanorin SCHEMBL22799168 0.83 CYP3A4 (0.72) KMT2APOLBCYP3A4HPGDMAPK1
SCHEMBL950536 0.82 CYP3A4 (1.00) KMT2APOLBCYP3A4HPGDMAPK1
Ethyl Everninate SCHEMBL1640418 0.78 CYP3A4 (1.00) KMT2APOLBCYP3A4HPGDMAPK1
Ethyl Everninate SCHEMBL31233848 0.78 CYP3A4 (1.00) KMT2APOLBCYP3A4HPGDMAPK1
SCHEMBL4263528 0.76 CYP3A4 (0.71) KMT2APOLBCYP3A4HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001999-A1 HYDROPHILIC OIL REPELLENT POLYMER SUMITOMO CHEMICAL CO (JP) 2026-01-01 US disclosed
EP-4578894-A1 HYDROPHILIC OIL REPELLENT POLYMER Sumitomo Chemical Company, Limited (JP) 2025-07-02 EP disclosed
EP-4578895-A1 POLYMER, RESIN COMPOSITION, MOLDED BODY, AND POLYMER PRODUCTION METHOD Sumitomo Chemical Company, Limited (JP) 2025-07-02 EP disclosed
WO-2024043326-A1 HYDROPHILIC OIL REPELLENT POLYMER 住友化学株式会社 2024-02-29 WO disclosed
WO-2024043327-A1 POLYMER, RESIN COMPOSITION, MOLDED BODY, AND POLYMER PRODUCTION METHOD 住友化学株式会社 2024-02-29 WO disclosed
US-20230129965-A1 HYDROPHILIC AND OLEOPHOBIC POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US disclosed
EP-4130057-A1 HYDROPHILIC OIL REPELLENT POLYMER Sumitomo Chemical Company, Limited (JP) 2023-02-08 EP disclosed
CN-115362182-A Hydrophilic oil-repellent polymers 住友化学株式会社 2022-11-18 CN disclosed
US-11459445-B2 Composition and molded body SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-10-04 US disclosed
CN-111684019-B Composition and molded article 住友化学株式会社 2022-08-02 CN disclosed
US-20210054169-A1 COMPOSITION AND MOLDED BODY SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-02-25 US disclosed
EP-3753986-A1 COMPOSITION AND MOLDED BODY SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2020-12-23 EP disclosed
CN-111684019-A Composition and molded article 住友化学株式会社 2020-09-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001999-A1 HYDROPHILIC OIL REPELLENT POLYMER CCR1, H1-3, CCR3 KMT2A 1993/4885POLB 1575/4885CYP3A4 3394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.